InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Gerngross Tillman U., Director. Director active across 2 companies, notably Adagio Therapeutics, Inc.. In total, 3 reports have been published. The latest transaction was filed on 16 June 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations3 total
09,459 shares0
Common Stock
SEC:0001209191-22-038538:0·
25,860,700 shares
Common Stock
SEC:0001209191-21-051296·
25,860,700 shares
Common Stock
SEC:0001209191-21-051296:0·
3 of 3 declarations
About Gerngross Tillman U.
Tillman U. Gerngross is the Chief Executive Officer and Director at Adagio Therapeutics, Inc. and Alector, Inc. He leads the strategic and business operations of both companies, focusing on innovation in the biopharmaceutical sector. His leadership is essential in guiding the vision and growth of the companies.
